Moneycontrol
Nov 14, 2017 01:17 PM IST | Source: Moneycontrol.com

Dr Reddy's Laboratories launched Clofarabine injection in US market

Dr Reddy's Laboratories has launched Clofarabine Injection, a therapeutic equivalent generic version of Clolar injection in the US Market, approved by USFDA.

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Dr Reddy's Laboratories has launched Clofarabine Injection, a therapeutic equivalent generic version of Clolar injection in the US Market, approved by USFDA.

At 13:10 hrs Dr Reddys Laboratories was quoting at Rs 2,346.40, up Rs 2.25, or 0.10 percent.


The share touched its 52-week high Rs 3,345.00 and 52-week low Rs 1,901.65 on 16 November, 2016 and 11 August, 2017, respectively.

Currently, it is trading 29.85 percent below its 52-week high and 23.39 percent above its 52-week low.

Market capitalisation stands at Rs 38,921.91 crore Source : BSE
Sections
Follow us on
Available On